UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 2.005

Sortiert nach

174G>C interleukin-6 gene polymorphism in Tunisian patients with coronary artery disease

Annals of Saudi medicine, 2011-01, Vol.31 (1), p.40-44

2011

Volltextzugriff (PDF)

174G>C Interleukin-6 Gene Polymorphism in Tunisian Patients with Coronary Artery Disease

Annals of Saudi medicine, 2011-01, Vol.31 (1), p.40-44

2011

Volltextzugriff (PDF)

2-Day versus C-reactive protein guided antibiotherapy with levofloxacin in acute COPD exacerbation: A randomized controlled trial

PloS one, 2021-05, Vol.16 (5), p.e0251716

2021

Volltextzugriff (PDF)

(2 Z )-2-( H ydroximino)-3-methoxy-3-phenyl-2,3-dihydro-1 H -imidazo[1,2- a ]pyrimidin-4-ium perchlorate

Acta crystallographica. Section E, Structure reports online, 2004-10, Vol.60 (10), p.o1719-o1721

2004

Volltextzugriff (PDF)

O.21 Genetic characterisation of PHARC – a novel syndrome resembling Refsum’s disease

Neuromuscular disorders : NMD, 2010-10, Vol.20 (9), p.680-680

2010

Volltextzugriff (PDF)

267 Épidémiologie des uvéites postérieures dans un centre hospitalier à Tunis

Journal français d'ophtalmologie, 2007-04, Vol.30, p.2S228-2S228

2007

Volltextzugriff (PDF)

(2Z)‐2‐(Hydroximino)‐3‐methoxy‐3‐phenyl‐2,3‐dihydro‐1H‐imidazo[1,2‐a]pyrimidin‐4‐ium perchlorate

Acta crystallographica. Section E, Structure reports online, 2004-10, Vol.60 (10), p.o1719-o1721

2004

Volltextzugriff (PDF)

3‐Nitroso‐2‐phenylimidazo[1,2‐a]pyrimidine

Acta crystallographica. Section E, Structure reports online, 2004-07, Vol.60 (7), p.o1131-o1132

2004

Volltextzugriff (PDF)

3-Nitroso-2-phenylimidazo[1,2- a ]pyrimidine

Acta crystallographica. Section E, Structure reports online, 2004-07, Vol.60 (7), p.o1131-o1132

2004

Volltextzugriff (PDF)

308G>A and –1031T>C tumor necrosis factor gene polymorphisms in Tunisian patients with coronary artery disease

Clinical chemistry and laboratory medicine, 2009-10, Vol.47 (10), p.1247-1251

2009

Volltextzugriff (PDF)

32e Congrès national de la STPI 2e Congrès francophone de Pathologie infectieuse et Microbiologie clinique 5 au 7 mai 2023, Hammamet, Tunisie

Médecine tropicale et santé internationale, 2023-12, Vol.3 (4)

2023

Volltextzugriff (PDF)

32nd National STPI Congress 2nd French-speaking Congress of Infectious Pathology and Clinical Microbiology 5 to 7 May 2023, Hammamet, Tunisia

Médecine tropicale et santé internationale, 2023-12, Vol.3 (4)

2023

Volltextzugriff (PDF)

4′‐(4‐Methoxyphenyl)‐3′‐phenylspiro[1H‐isothiachroman‐3,5′‐isoxazolidin]‐4(2H)‐one

Acta crystallographica. Section E, Structure reports online, 2006-03, Vol.62 (3), p.o1101-o1102

2006

Volltextzugriff (PDF)

4′-(4-Methoxyphenyl)-3′-phenylspiro[1 H -isothiachroman-3,5′-isoxazolidin]-4(2 H )-one

Acta crystallographica. Section E, Structure reports online, 2006-03, Vol.62 (3), p.o1101-o1102

2006

Volltextzugriff (PDF)

4'-Methyl-3-(4-nitro-phen-yl)-4-phenyl-4,5,1',2',3',4'-hexa-hydro-spiro-[isoxazole-5,2'-naphthalen]-1'-one

Acta crystallographica. Section E, Structure reports online, 2008-01, Vol.64 (Pt 2), p.o509-o510

2008

Volltextzugriff (PDF)

4′-Methyl-3-(4-nitrophenyl)-4-phenyl-4,5,1′,2′,3′,4′-hexahydrospiro[isoxazole-5,2′-naphthalen]-1′-one

Acta crystallographica. Section E, Structure reports online, 2008-02, Vol.64 (2), p.o509-o510

2008

Volltextzugriff (PDF)

4CPS-016 Inappropriate use of human albumin in a teaching hospital

European journal of hospital pharmacy. Science and practice, 2020-03, Vol.27 (Suppl 1), p.A54-A55

2020

Volltextzugriff (PDF)

4D reservoir geomechanics: a case study from the HP/HT reservoirs of the Elgin and Franklin fields

First break, 2008-12, Vol.26 (12)

2008

Volltextzugriff (PDF)

5‐(2‐Chlorobenzyl)‐2‐(2‐hydroxyethyl)‐6‐methylpyridazin‐3(2H)‐one

Acta crystallographica. Section E, Structure reports online, 2003-07, Vol.59 (7), p.o1041-o1042

2003

Volltextzugriff (PDF)

5-(2-Chlorobenzyl)-2-(2-hydroxyethyl)-6-methylpyridazin-3(2 H )-one

Acta crystallographica. Section E, Structure reports online, 2003-07, Vol.59 (7), p.o1041-o1042

2003

Volltextzugriff (PDF)

5203 THE INCESSANT QUEST FOR DRY WEIGHT: SHOULD WE ADOPT NEW STRATEGIES?

Nephrology, dialysis, transplantation, 2023-06, Vol.38 (Supplement_1)

2023

Volltextzugriff (PDF)

522 Aspergillus Niger: an Unusual Cause of Invasive Pulmonary Aspergillosis

Archives of disease in childhood, 2012-10, Vol.97 (Suppl 2), p.A152-A152

2012

Volltextzugriff (PDF)

5PSQ-132 Failure mode and effect analysis applied to the parenteral nutrition preparation process in a maternity and neonatal hospital

European journal of hospital pharmacy. Science and practice, 2021-03, Vol.28 (Suppl 1), p.A122-A122

2021

Volltextzugriff (PDF)

5PSQ-147 A systematic risk analysis method applied to the medical devices management process in a hospital pharmacy

European journal of hospital pharmacy. Science and practice, 2022-03, Vol.29 (Suppl 1), p.A164-A164

2022

Volltextzugriff (PDF)

6‐Phenyl‐4,5‐dihydropyridazin‐3(2H)‐one

Acta crystallographica. Section E, Structure reports online, 2003-06, Vol.59 (6), p.o802-o803

2003

Volltextzugriff (PDF)

1 – 25 von 2.005

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.521)
Mit Volltextzugriff
(1.787)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

6 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(833)
Technology
(363)
Life Sciences & Biomedicine
(338)
Physical Sciences
(244)
Humans
(241)
Engineering
(234)
Female
(158)
Engineering, Electrical & Electronic
(134)
Male
(128)
Adult
(106)
Computer Science
(102)
Chemistry
(101)
Physics
(100)
Middle Aged
(87)
Tunisia
(82)
Energy & Fuels
(64)
Internal Medicine
(62)
Exact Sciences And Technology
(59)
Science & Technology - Other Topics
(58)
Life Sciences
(55)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

174G>C interleukin-6 gene polymorphism in Tunisian patients with coronary artery disease

174G>C Interleukin-6 Gene Polymorphism in Tunisian Patients with Coronary Artery Disease

2-Day versus C-reactive protein guided antibiotherapy with levofloxacin in acute COPD exacerbation: A randomized controlled trial

(2 Z )-2-( H ydroximino)-3-methoxy-3-phenyl-2,3-dihydro-1 H -imidazo[1,2- a ]pyrimidin-4-ium perchlorate

O.21 Genetic characterisation of PHARC – a novel syndrome resembling Refsum’s disease

267 Épidémiologie des uvéites postérieures dans un centre hospitalier à Tunis

(2Z)‐2‐(Hydroximino)‐3‐methoxy‐3‐phenyl‐2,3‐dihydro‐1H‐imidazo[1,2‐a]pyrimidin‐4‐ium perchlorate

3‐Nitroso‐2‐phenylimidazo[1,2‐a]pyrimidine

3-Nitroso-2-phenylimidazo[1,2- a ]pyrimidine

308G>A and –1031T>C tumor necrosis factor gene polymorphisms in Tunisian patients with coronary artery disease

32e Congrès national de la STPI 2e Congrès francophone de Pathologie infectieuse et Microbiologie clinique 5 au 7 mai 2023, Hammamet, Tunisie

32nd National STPI Congress 2nd French-speaking Congress of Infectious Pathology and Clinical Microbiology 5 to 7 May 2023, Hammamet, Tunisia

4′‐(4‐Methoxyphenyl)‐3′‐phenylspiro[1H‐isothiachroman‐3,5′‐isoxazolidin]‐4(2H)‐one

4′-(4-Methoxyphenyl)-3′-phenylspiro[1 H -isothiachroman-3,5′-isoxazolidin]-4(2 H )-one

4'-Methyl-3-(4-nitro-phen-yl)-4-phenyl-4,5,1',2',3',4'-hexa-hydro-spiro-[isoxazole-5,2'-naphthalen]-1'-one

4′-Methyl-3-(4-nitrophenyl)-4-phenyl-4,5,1′,2′,3′,4′-hexahydrospiro[isoxazole-5,2′-naphthalen]-1′-one

4CPS-016 Inappropriate use of human albumin in a teaching hospital

4D reservoir geomechanics: a case study from the HP/HT reservoirs of the Elgin and Franklin fields

5‐(2‐Chlorobenzyl)‐2‐(2‐hydroxyethyl)‐6‐methylpyridazin‐3(2H)‐one

5-(2-Chlorobenzyl)-2-(2-hydroxyethyl)-6-methylpyridazin-3(2 H )-one

5203 THE INCESSANT QUEST FOR DRY WEIGHT: SHOULD WE ADOPT NEW STRATEGIES?

522 Aspergillus Niger: an Unusual Cause of Invasive Pulmonary Aspergillosis

5PSQ-132 Failure mode and effect analysis applied to the parenteral nutrition preparation process in a maternity and neonatal hospital

5PSQ-147 A systematic risk analysis method applied to the medical devices management process in a hospital pharmacy

6‐Phenyl‐4,5‐dihydropyridazin‐3(2H)‐one

Suchergebnisse filtern